データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
2503-44-8CC(=O)Cc1ccc(O)c(O)c1JQXBETDGCMQLMK-UHFFFAOYSA-N3,4-Dihydroxyphenylacetone is an alkylbenzene.
2503-44-8DTXSID90179739CHEMBL3638320CHEBI:173748Thick Yellow Oil
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
説明3'',4''-Dihydroxyphenylacetone (Item No. 19522) is an analytical reference standard. It is a minor metabolite of 3,4-MDEA (Item Nos. 14085 | 15689), MDMA, and α-methyldopa produced by oxidative deamination. This product is intended for forensic and research applications.
説明3',4'-Dihydroxypropiophenone, also known as DOPA, is a metabolite of dopamine, which is produced in the brain and kidneys. DOPA is a precursor to the synthesis of melanin, which is found in skin cells. Glutamate dehydrogenase converts DOPA to 3-methoxytyramine, which can be detected chromatographically in urine samples. Examining a urine sample for DOPA testing can be used to diagnose Parkinson's disease. DOPA may also be detected in plasma in patients with bacterial and urinary tract infections
使用A metabolite of racemic 3,4-methylenedioxyethylamphetamine.
3,4-dihydroxylphenylacetaldehyde (DHPAA) synthase catalyzes a complicated decarboxylation-deamination process of α-methyl dopa (AMD), leading to the production of 3,4-dihydroxyphenylacetone.
現在のフィルター条件では反応記録がありません。
読み込み中…